CYDY lining all its ducks up in a row basically no leaf left unturned between the whole amarex debacle trail data etc and now finances. Certainly sounds like a big potential near future partner is getting a close look exactly who they are getting into bed with. This is all steps in the right direction it should be an easy uplist when the day comes that SP is high enough for up-listing. The days of bashers claiming bankruptcy should be layed to rest. When clinical hold lifted Leronlimab impeccable Safety should never not in question… i mean in the cd10 trial it was literally safer than water. Lots of catalyst to look forward to